JP2025524457A5 - - Google Patents
Info
- Publication number
- JP2025524457A5 JP2025524457A5 JP2024575443A JP2024575443A JP2025524457A5 JP 2025524457 A5 JP2025524457 A5 JP 2025524457A5 JP 2024575443 A JP2024575443 A JP 2024575443A JP 2024575443 A JP2024575443 A JP 2024575443A JP 2025524457 A5 JP2025524457 A5 JP 2025524457A5
- Authority
- JP
- Japan
- Prior art keywords
- targeting module
- receptor
- tag
- binding domain
- chimeric antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22180805.8 | 2022-06-23 | ||
| EP22180805.8A EP4296281A1 (en) | 2022-06-23 | 2022-06-23 | Targeting modules against cd123 and a tag for use in a method for stimulating a universal chimeric antigen receptor-mediated immune response in a mammal |
| EP23168260.0 | 2023-04-17 | ||
| EP23168260 | 2023-04-17 | ||
| PCT/US2023/068998 WO2023250489A1 (en) | 2022-06-23 | 2023-06-23 | Targeting modules against cd123 for use in a method for stimulating a chimeric antigen receptor-mediated immune response in a mammal |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025524457A JP2025524457A (ja) | 2025-07-30 |
| JP2025524457A5 true JP2025524457A5 (https=) | 2026-04-06 |
Family
ID=87281111
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024575443A Pending JP2025524457A (ja) | 2022-06-23 | 2023-06-23 | 哺乳動物におけるキメラ抗原受容体介在性の免疫応答を刺激するための方法において使用するためのｃｄ１２３に対する標的化モジュール |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250269025A1 (https=) |
| EP (1) | EP4543922A1 (https=) |
| JP (1) | JP2025524457A (https=) |
| CN (1) | CN119790072A (https=) |
| AU (1) | AU2023289687A1 (https=) |
| CA (1) | CA3258275A1 (https=) |
| WO (1) | WO2023250489A1 (https=) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2990416B1 (en) | 2014-08-29 | 2018-06-20 | GEMoaB Monoclonals GmbH | Universal chimeric antigen receptor expressing immune cells for targeting of diverse multiple antigens and method of manufacturing the same and use of the same for treatment of cancer, infections and autoimmune disorders |
| EP3581200A1 (en) | 2018-06-13 | 2019-12-18 | GEMoaB Monoclonals GmbH | Reversed universal chimeric antigen receptor expressing immune cells for targeting of diverse multiple antigens and method of manufacturing the same and use of the same for treatment of cancer, infections and autoimmune disorders |
-
2023
- 2023-06-23 AU AU2023289687A patent/AU2023289687A1/en active Pending
- 2023-06-23 WO PCT/US2023/068998 patent/WO2023250489A1/en not_active Ceased
- 2023-06-23 JP JP2024575443A patent/JP2025524457A/ja active Pending
- 2023-06-23 CN CN202380060615.0A patent/CN119790072A/zh active Pending
- 2023-06-23 CA CA3258275A patent/CA3258275A1/en active Pending
- 2023-06-23 EP EP23741575.7A patent/EP4543922A1/en active Pending
- 2023-06-23 US US18/878,321 patent/US20250269025A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3490585B1 (en) | Immunomodulatory polypeptides and related compositions and methods | |
| US20250213708A1 (en) | Chimeric transmembrane proteins and uses thereof | |
| CA3059444A1 (en) | Chimeric antigen receptor t cells targeting the tumor microenvironment | |
| US20130289261A1 (en) | Therapeutic and diagnostic cloned mhc-unrestricted receptor specific for the muc1 tumor associated antigen | |
| EP3568406A1 (en) | T cells expressing a chimeric antigen receptor | |
| EP3704156A1 (en) | Cd38-directed chimeric antigen receptor constructs | |
| JP2023527621A5 (https=) | ||
| JP2023527621A (ja) | 哺乳類におけるキメラ抗原受容体媒介性免疫応答を刺激するための方法における使用のための、ｐｄ－ｌ１および／またはｐｄ－ｌ２を含む標的化モジュール | |
| JP2025524457A5 (https=) | ||
| EP4176895A1 (en) | Targeting modules against il13ra2 or her2 for use in combination with a chimeric antigen receptor | |
| US20250269025A1 (en) | Targeting modules against cd123 for use in a method for stimulating a chimeric antigen receptor-mediated immune response in a mammal | |
| KR20240034205A (ko) | 항EGFRviii 항체, 폴리펩타이드, 상기 폴리펩타이드를 발현하는 세포, 상기 세포를 포함하는 의약 조성물, 상기 세포의 제조 방법 및 상기 폴리펩타이드를 코딩하는 염기서열을 포함하는 폴리뉴클레오티드 또는 벡터 | |
| EP4566619A1 (en) | Targeting modules against cd19 and cd20 for use in a method for stimulating a reversed chimeric antigen receptor-mediated immune response in a mammal | |
| EP4296281A1 (en) | Targeting modules against cd123 and a tag for use in a method for stimulating a universal chimeric antigen receptor-mediated immune response in a mammal | |
| EP4566620A1 (en) | Switchable universal chimeric antigen receptors and their use | |
| AU2024393901A1 (en) | Targeting modules against cd19 and cd20 for use in a method for stimulating a reversed | |
| HK40125822A (en) | Targeting modules against cd19 and cd20 for use in a method for stimulating a reversed chimeric antigen receptor-mediated immune response in a mammal | |
| US20250121007A1 (en) | Compositions for the treatment of cancer | |
| HK40125821A (en) | Switchable universal chimeric antigen receptors and their use | |
| WO2024121297A1 (en) | A kit for use in the treatment of hematological cancer | |
| CN117999344A (zh) | Nkg2d嵌合抗原受体和pd1抑制剂联合治疗癌症的方法和药物 | |
| CN117881695A (zh) | 功能强化的新型嵌合抗原受体 |